Key data from the 2023 European Thyroid Association congress: Breakthrough advances in the treatment of Graves' orbitopathy

Ann Endocrinol (Paris). 2024 Apr;85(2):150-151. doi: 10.1016/j.ando.2024.01.001. Epub 2024 Jan 17.

Authors

Miriam Ladsous¹, Philippe Caron²

Affiliations

¹ Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital, Lille, France.
² Department of Endocrinology and Metabolic diseases, Pôle Cardio-Vasculaire et Métabolique, CHU Larrey, 24, chemin de Pouvourville, TSA 30030, 31059 Toulouse cedex, France. Electronic address: caron.p@chu-toulouse.fr.

PMID: 38307804
DOI: 10.1016/j.ando.2024.01.001

No abstract available

Publication types

Letter

MeSH terms

Glucocorticoids
Graves Disease*
Graves Ophthalmopathy* / therapy
Humans

Substances

Glucocorticoids